Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Non-Current Assets: 2018-2020

Historic Non-Current Assets for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $10.1 million.

  • Black Diamond Therapeutics' Non-Current Assets rose 225.57% to $32.6 million in Q3 2021 from the same period last year, while for Sep 2021 it was $32.6 million, marking a year-over-year increase of 225.57%. This contributed to the annual value of $10.1 million for FY2020, which is 291.94% up from last year.
  • As of FY2020, Black Diamond Therapeutics' Non-Current Assets stood at $10.1 million, which was up 291.94% from $2.6 million recorded in FY2019.
  • In the past 5 years, Black Diamond Therapeutics' Non-Current Assets ranged from a high of $10.1 million in FY2020 and a low of $142,000 during FY2018.
  • Moreover, its 3-year median value for Non-Current Assets was $2.6 million (2019), whereas its average is $4.3 million.
  • Data for Black Diamond Therapeutics' Non-Current Assets shows a peak YoY soared of 1,717.61% (in 2019) over the last 5 years.
  • Black Diamond Therapeutics' Non-Current Assets (Yearly) stood at $142,000 in 2018, then soared by 1,717.61% to $2.6 million in 2019, then spiked by 291.94% to $10.1 million in 2020.